Skip to main content
LYSOGENE logo

LYSOGENE — Investor Relations & Filings

Ticker · LYS ISIN · FR0013233475 LEI · 969500T64RILK1RD0852 PA Professional, scientific and technical activities
Open in API
Filings indexed 254 across all filing types
Latest filing 2022-10-24 Interim / Quarterly Rep…
Country FR France
Listing PA LYS

About LYSOGENE

https://www.lysogene.com

Lysogene was a clinical-stage biotechnology company that specialized in the research and development of gene therapies for rare, inherited neurodegenerative diseases affecting the central nervous system (CNS). The company's approach focused on delivering a functional copy of a deficient gene directly to the brain to address the root cause of the targeted disorder. Its pipeline included investigational treatments for lysosomal storage diseases such as Sanfilippo syndrome type A (MPS IIIA) and GM1 gangliosidosis. Following clinical and financial challenges, the company initiated judicial liquidation proceedings in 2023.

Recent filings

Filing Released Lang Actions
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
Interim / Quarterly Report Classification · 1% confidence The document is titled 'RAPPORT FINANCIER SEMESTRIEL 2022' (Semi-Annual Financial Report 2022) for Lysogene. It contains comprehensive financial statements (balance sheet, income statement, cash flow), management's analysis of financial results, and an audit report summary for the six-month period ending June 30, 2022. It meets the criteria for an Interim/Quarterly Report as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H2 2022
2022-10-24 French
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and its primary content announces a renewal of the company's Board of Directors ('nouveau Conseil d'administration'), including the co-option of new members and the departure of others. This directly relates to changes in senior governance personnel. According to the definitions, 'Board/Management Information' (MANG) covers the 'Announcement of changes in the company's board of directors or senior management.' The document is a formal announcement, not a full regulatory report like a 10-K or IR, nor is it a general regulatory filing (RNS) since a more specific category applies. Therefore, MANG is the most appropriate classification.
2022-09-16 French
Inside Information / Other news releases
Board/Management Information Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces "New Board of Directors" appointments and changes. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The content details the co-option of new directors and the departure of existing ones, confirming this classification. It is not an Annual Report (10-K), an Earnings Release (ER), or a proxy statement (DEF 14A/PSI).
2022-09-16 English
Inside Information / News release on accounts, results
Earnings Release Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and reports on the company's "Cash Position as of 30 June 2022." This format, focusing on key financial highlights (cash balance, cash runway) immediately following a period end, is characteristic of an Earnings Release (ER), which provides initial announcements of periodical financial results. It is not a comprehensive report (like 10-K or IR), nor is it a transcript (CT) or a formal presentation (IP). Since it is a press release announcing key financial figures, ER is the most appropriate classification. H1 2022
2022-07-21 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the company's cash position as of June 30, 2022. It provides key financial highlights (cash balance) for a specific period (quarter-end) but is not the comprehensive quarterly report itself (which would be an IR). It is a brief announcement summarizing key financial status updates, which aligns best with an Earnings Release (ER), even though it focuses only on cash and not full P&L/Balance Sheet figures. The length (5085 chars) is substantial for a simple press release but the content structure is typical of an initial results announcement before the full report is filed. Given the focus on period-end financial status, ER is the most appropriate classification over a general Regulatory Filing (RNS). H1 2022
2022-07-21 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and specifically details the "Bilan semestriel du contrat de liquidité" (Semi-annual report of the liquidity contract) managed by Kepler Cheuvreux, dated July 11, 2022, covering the period up to June 30, 2022. This document reports on the status of a liquidity agreement, including share counts, cash balances, and transaction volumes. This type of regular, periodic disclosure regarding market making or liquidity provision activities, often mandated by regulators like the AMF (mentioned in the text), is a specific type of regulatory announcement. It is not a full Annual Report (10-K), an Interim Report (IR), or a standard Earnings Release (ER). Since it is a specific regulatory disclosure concerning market activity and is not a general announcement about the publication of a major report (RPA), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for specific regulatory announcements that don't fit elsewhere, especially given the reference to AMF decisions regarding market practices.
2022-07-11 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.